דיפרופול % 1 ישראל - עברית - Ministry of Health

דיפרופול % 1

taro international ltd, israel - propofol - תחליב להזרקה או אינפוזיה - propofol 10 mg/ml - propofol - propofol - propofol is a short acting intravenous anesthetic agent suitable for induction and maintenance of general anesthesia in adults. propofol may also be used for sedation of ventilated adult patients in intensive care and for anesthesia in pediatric surgery (for children of 3 years of age or older ) for surgical procedures which do not exceed 1 hour in duration. propofol may also be used for conscious sedation for surgical and diagnostic procedures..

קצף אמבט וניל דבש ישראל - עברית - Ministry of Health

קצף אמבט וניל דבש

ש.שוורץ באר שבע בעמ - רחצת הגוף

סקין גארד - ספורט - תחליב SPF 34 ישראל - עברית - Ministry of Health

סקין גארד - ספורט - תחליב spf 34

זהר קוסמטיקס (מ.עו.פ) בעמ - הגנה מקרני שמש

תוריד 10 ישראל - עברית - Ministry of Health

תוריד 10

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 10 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains

תוריד 20 ישראל - עברית - Ministry of Health

תוריד 20

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 20 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains

תוריד 40 ישראל - עברית - Ministry of Health

תוריד 40

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 40 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains

תוריד 80 ישראל - עברית - Ministry of Health

תוריד 80

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 80 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains